The interrelationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis

被引:0
|
作者
Graesser, D
Mahooti, S
Haas, T
Davis, S
Clark, RB
Madri, JA
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Univ Connecticut, Sch Med, Dept Med, Div Rheumat Dis, Farmington, CT USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Previous studies have suggested that surface expression of alpha 4 integrin by autoreactive T-cell clones is necessary for the clones to induce experimental autoimmune encephalomyelitis (EAE), a mouse model for human multiple sclerosis. To provide direct evidence for this phenomenon, we have transfected alpha 4 integrin into C19 alpha 4-LO, a myelin basic protein-reactive T-cell clone that does not express alpha 4 integrin and does not induce EAE when adoptively transferred into a susceptible mouse strain. Transfection of alpha 4 integrin converted this clone to an alpha 4 integrin-expressing clone that induced EAE. We then examined potential mechanisms by which alpha 4 integrin may facilitate the disease process. C19 T-cell clones adhered equally to a monolayer of microvascular endothelial cells, regardless of level of alpha 4 integrin expression. However, in contrast to T-cell clones that do not express alpha 4 integrin, T-cell clones that express alpha 4 integrin (endogenously or by transfection) transmigrated through an endothelial cell layer and subendothelial matrix at an enhanced rate and adhered to recombinant vascular cell adhesion molecule-1 (rVCAM-1) and the CS1 fragment of fibronectin, and after adhesion to these ligands, a matrix-degrading metalloproteinase (MMP-2) was induced and activated. The clones were also shown to constitutively express the membrane-type matrix metalloproteinase (MT1-MMP), an enzyme that activates MMP-2. GM6001 and UK-221,316, inhibitors of metalloproteinases, reduced alpha 4 integrin-mediated transmigration and EAE induction by C19 T-cell clones. in addition, we studied a second EAE-inducing T-cell clone, MM4, which constitutively expresses alpha 4 integrin and MMP-2. Engagement of alpha 4 integrin on the MM4 clone up-regulated the expression and activation of MMP-2, without changing the expression of MT1-MMP. MMP inhibitors also reduced transmigration of and EAE induction by the MM4 T-cell clone. These studies demonstrate directly that expression of alpha 4 integrin by autoreactive T-cell clones is required for adoptive transfer of EAE in this model. We also define a role for alpha 4 integrin in the disease process in mediating the induction and coordinate activation of a matrix metalloproteinase (MMP-2), which facilitates T-cell transmigration.
引用
收藏
页码:1445 / 1458
页数:14
相关论文
共 50 条
  • [1] The role of matrix metalloproteinase-2 in the immunopathogenesis of experimental autoimmune encephalomyelitis in the mouse
    Esparza, J
    Kruse, MA
    Lee, JYM
    Madri, JA
    FASEB JOURNAL, 2004, 18 (05): : A1115 - A1115
  • [2] Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis
    Graesser, D
    Mahooti, S
    Madri, JA
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (02) : 121 - 131
  • [3] Distinct roles for matrix metalloproteinase-2 (MMP-2) and α4 integrin during autoimmune T cell entry and residency in brain parenchyma in experimental autoimmune encephalomyelitis (EAE).
    Graesser, DS
    Mahooti, S
    Madri, JA
    FASEB JOURNAL, 2000, 14 (04): : A287 - A287
  • [4] Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
    Banisadr, Ghazal
    Schwartz, Samantha R.
    Podojil, Joseph R.
    Piccinini, Linda A.
    Lanker, Stefan
    Miller, Stephen D.
    Miller, Richard J.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (03) : 438 - 445
  • [5] Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
    Ghazal Banisadr
    Samantha R. Schwartz
    Joseph R. Podojil
    Linda A. Piccinini
    Stefan Lanker
    Stephen D. Miller
    Richard J. Miller
    Journal of Neuroimmune Pharmacology, 2014, 9 : 438 - 445
  • [6] Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2
    Nygårdas, PT
    Grönberg, SAM
    Heikkilä, J
    Joronen, K
    Sorsa, T
    Hinkkanen, AE
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (04) : 372 - 381
  • [7] Matrix metalloproteinase-2 - The forgotten enzyme in aneurysm pathogenesis
    Thompson, Matt
    Cockerill, Gillian
    ABDOMINAL AORTIC ANEURYSM: GENETICS, PATHOPHYSIOLOGY AND MOLECULAR BIOLOGY, 2006, 1085 : 170 - 174
  • [8] Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
    Kieseier, BC
    Kiefer, R
    Clements, JM
    Miller, K
    Wells, GMA
    Schweitzer, T
    Gearing, AJH
    Hartung, HP
    BRAIN, 1998, 121 : 159 - 166
  • [9] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [10] Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application
    Skrzypiec-Spring, Monika
    Haczkiewicz, Katarzyna
    Sapa, Agnieszka
    Piasecki, Tomasz
    Kwiatkowska, Joanna
    Ceremuga, Ireneusz
    Wozniak, Mieczyslaw
    Biczysko, Wieslawa
    Kobierzycki, Christopher
    Dziegiel, Piotr
    Podhorska-Okolow, Marzenna
    Szelag, Adam
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (01) : 89 - 97